Literature DB >> 19541654

Structural and kinetic modeling of an activating helix switch in the rhodopsin-transducin interface.

Patrick Scheerer1, Martin Heck, Andrean Goede, Jung Hee Park, Hui-Woog Choe, Oliver P Ernst, Klaus Peter Hofmann, Peter W Hildebrand.   

Abstract

Extracellular signals prompt G protein-coupled receptors (GPCRs) to adopt an active conformation (R*) and catalyze GDP/GTP exchange in the alpha-subunit of intracellular G proteins (Galphabetagamma). Kinetic analysis of transducin (G(t)alphabetagamma) activation shows that an intermediary R*xG(t)alphabetagamma.GDP complex is formed that precedes GDP release and formation of the nucleotide-free R*xG protein complex. Based on this reaction sequence, we explore the dynamic interface between the proteins during formation of these complexes. We start from the R* conformation stabilized by a G(t)alpha C-terminal peptide (GalphaCT) obtained from crystal structures of the GPCR opsin. Molecular modeling allows reconstruction of the fully elongated C-terminal alpha-helix of G(t)alpha (alpha5) and shows how alpha5 can be docked to the open binding site of R*. Two modes of interaction are found. One of them--termed stable or S-interaction--matches the position of the GalphaCT peptide in the crystal structure and reproduces the hydrogen-bonding networks between the C-terminal reverse turn of GalphaCT and conserved E(D)RY and NPxxY(x)(5,6)F regions of the GPCR. The alternative fit--termed intermediary or I-interaction--is distinguished by a tilt (42 degrees ) and rotation (90 degrees ) of alpha5 relative to the S-interaction and shows different alpha5 contacts with the NPxxY(x)(5,6)F region and the second cytoplasmic loop of R*. From the 2 alpha5 interactions, we derive a "helix switch" mechanism for the transition of R*xG(t)alphabetagamma.GDP to the nucleotide-free R*xG protein complex that illustrates how alpha5 might act as a transmission rod to propagate the conformational change from the receptor-G protein interface to the nucleotide binding site.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19541654      PMCID: PMC2705592          DOI: 10.1073/pnas.0900072106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  52 in total

1.  Mapping of contact sites in complex formation between transducin and light-activated rhodopsin by covalent crosslinking: use of a photoactivatable reagent.

Authors:  K Cai; Y Itoh; H G Khorana
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

2.  Maximal rate and nucleotide dependence of rhodopsin-catalyzed transducin activation: initial rate analysis based on a double displacement mechanism.

Authors:  M Heck; K P Hofmann
Journal:  J Biol Chem       Date:  2000-12-14       Impact factor: 5.157

3.  Crystal structure of rhodopsin: A G protein-coupled receptor.

Authors:  K Palczewski; T Kumasaka; T Hori; C A Behnke; H Motoshima; B A Fox; I Le Trong; D C Teller; T Okada; R E Stenkamp; M Yamamoto; M Miyano
Journal:  Science       Date:  2000-08-04       Impact factor: 47.728

4.  Probing the mechanism of rhodopsin-catalyzed transducin activation.

Authors:  M Natochin; M Moussaif; N O Artemyev
Journal:  J Neurochem       Date:  2001-04       Impact factor: 5.372

5.  The amino terminus of the fourth cytoplasmic loop of rhodopsin modulates rhodopsin-transducin interaction.

Authors:  E P Marin; A G Krishna; T A Zvyaga; J Isele; F Siebert; T P Sakmar
Journal:  J Biol Chem       Date:  2000-01-21       Impact factor: 5.157

Review 6.  Receptor-mediated activation of heterotrimeric G-proteins: current structural insights.

Authors:  Christopher A Johnston; David P Siderovski
Journal:  Mol Pharmacol       Date:  2007-04-12       Impact factor: 4.436

Review 7.  Heterotrimeric G protein activation by G-protein-coupled receptors.

Authors:  William M Oldham; Heidi E Hamm
Journal:  Nat Rev Mol Cell Biol       Date:  2008-01       Impact factor: 94.444

8.  High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor.

Authors:  Vadim Cherezov; Daniel M Rosenbaum; Michael A Hanson; Søren G F Rasmussen; Foon Sun Thian; Tong Sun Kobilka; Hee-Jung Choi; Peter Kuhn; William I Weis; Brian K Kobilka; Raymond C Stevens
Journal:  Science       Date:  2007-10-25       Impact factor: 47.728

9.  Crystal structure of the human beta2 adrenergic G-protein-coupled receptor.

Authors:  Søren G F Rasmussen; Hee-Jung Choi; Daniel M Rosenbaum; Tong Sun Kobilka; Foon Sun Thian; Patricia C Edwards; Manfred Burghammer; Venkata R P Ratnala; Ruslan Sanishvili; Robert F Fischetti; Gebhard F X Schertler; William I Weis; Brian K Kobilka
Journal:  Nature       Date:  2007-10-21       Impact factor: 49.962

10.  Hydrogen-bonding and packing features of membrane proteins: functional implications.

Authors:  Peter Werner Hildebrand; Stefan Günther; Andrean Goede; Lucy Forrest; Cornelius Frömmel; Robert Preissner
Journal:  Biophys J       Date:  2007-10-05       Impact factor: 4.033

View more
  19 in total

1.  Effect of channel mutations on the uptake and release of the retinal ligand in opsin.

Authors:  Ronny Piechnick; Eglof Ritter; Peter W Hildebrand; Oliver P Ernst; Patrick Scheerer; Klaus Peter Hofmann; Martin Heck
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-19       Impact factor: 11.205

Review 2.  Recognition in the face of diversity: interactions of heterotrimeric G proteins and G protein-coupled receptor (GPCR) kinases with activated GPCRs.

Authors:  Chih-chin Huang; John J G Tesmer
Journal:  J Biol Chem       Date:  2011-01-03       Impact factor: 5.157

3.  Interaction of a G protein with an activated receptor opens the interdomain interface in the alpha subunit.

Authors:  Ned Van Eps; Anita M Preininger; Nathan Alexander; Ali I Kaya; Scott Meier; Jens Meiler; Heidi E Hamm; Wayne L Hubbell
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-23       Impact factor: 11.205

4.  In vivo optophysiology reveals that G-protein activation triggers osmotic swelling and increased light scattering of rod photoreceptors.

Authors:  Pengfei Zhang; Robert J Zawadzki; Mayank Goswami; Phuong T Nguyen; Vladimir Yarov-Yarovoy; Marie E Burns; Edward N Pugh
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-20       Impact factor: 11.205

5.  Assembly of a GPCR-G Protein Complex.

Authors:  Yang Du; Nguyen Minh Duc; Søren G F Rasmussen; Daniel Hilger; Xavier Kubiak; Liwen Wang; Jennifer Bohon; Hee Ryung Kim; Marcin Wegrecki; Awuri Asuru; Kyung Min Jeong; Jeongmi Lee; Mark R Chance; David T Lodowski; Brian K Kobilka; Ka Young Chung
Journal:  Cell       Date:  2019-05-09       Impact factor: 41.582

6.  From molecular details of the interplay between transmembrane helices of the thyrotropin receptor to general aspects of signal transduction in family a G-protein-coupled receptors (GPCRs).

Authors:  Gunnar Kleinau; Inna Hoyer; Annika Kreuchwig; Ann-Karin Haas; Claudia Rutz; Jens Furkert; Catherine L Worth; Gerd Krause; Ralf Schülein
Journal:  J Biol Chem       Date:  2011-05-17       Impact factor: 5.157

Review 7.  The cytoplasmic rhodopsin-protein interface: potential for drug discovery.

Authors:  Naveena Yanamala; Eric Gardner; Alec Riciutti; Judith Klein-Seetharaman
Journal:  Curr Drug Targets       Date:  2012-01       Impact factor: 3.465

8.  Principles and determinants of G-protein coupling by the rhodopsin-like thyrotropin receptor.

Authors:  Gunnar Kleinau; Holger Jaeschke; Catherine L Worth; Sandra Mueller; Jorge Gonzalez; Ralf Paschke; Gerd Krause
Journal:  PLoS One       Date:  2010-03-18       Impact factor: 3.240

Review 9.  Novel insights on thyroid-stimulating hormone receptor signal transduction.

Authors:  Gunnar Kleinau; Susanne Neumann; Annette Grüters; Heiko Krude; Heike Biebermann
Journal:  Endocr Rev       Date:  2013-05-03       Impact factor: 19.871

10.  Comparative sequence and structural analyses of G-protein-coupled receptor crystal structures and implications for molecular models.

Authors:  Catherine L Worth; Gunnar Kleinau; Gerd Krause
Journal:  PLoS One       Date:  2009-09-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.